Concepts (790)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 61 | 2021 | 11216 | 3.510 |
Why?
|
| Prostate | 23 | 2020 | 1782 | 2.950 |
Why?
|
| Urinary Bladder Neoplasms | 26 | 2020 | 2244 | 2.870 |
Why?
|
| Kidney Neoplasms | 21 | 2020 | 4271 | 2.220 |
Why?
|
| Prostatectomy | 16 | 2019 | 1905 | 1.880 |
Why?
|
| Carcinoma, Renal Cell | 16 | 2020 | 3172 | 1.820 |
Why?
|
| Urinary Bladder | 7 | 2019 | 1168 | 1.300 |
Why?
|
| Urogenital Neoplasms | 2 | 2020 | 135 | 1.160 |
Why?
|
| Adenocarcinoma | 17 | 2020 | 6298 | 1.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 19 | 2020 | 8355 | 1.100 |
Why?
|
| Urethral Neoplasms | 2 | 2020 | 37 | 1.090 |
Why?
|
| Carcinoma, Transitional Cell | 7 | 2019 | 797 | 1.010 |
Why?
|
| Cystectomy | 7 | 2019 | 687 | 0.970 |
Why?
|
| Prognosis | 43 | 2020 | 29068 | 0.920 |
Why?
|
| Prostate-Specific Antigen | 15 | 2019 | 2511 | 0.910 |
Why?
|
| Neoplasm Staging | 14 | 2020 | 11064 | 0.890 |
Why?
|
| Occupational Therapy | 2 | 2023 | 134 | 0.860 |
Why?
|
| MicroRNAs | 7 | 2019 | 3742 | 0.810 |
Why?
|
| Disease Progression | 21 | 2019 | 13303 | 0.700 |
Why?
|
| Aromatase | 3 | 2020 | 146 | 0.670 |
Why?
|
| Prostatic Hyperplasia | 9 | 2020 | 526 | 0.650 |
Why?
|
| Activities of Daily Living | 6 | 2022 | 2379 | 0.620 |
Why?
|
| Succinate Dehydrogenase | 2 | 2018 | 145 | 0.620 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 5 | 2020 | 69 | 0.610 |
Why?
|
| Cushing Syndrome | 3 | 2010 | 242 | 0.610 |
Why?
|
| Calcium Signaling | 3 | 2019 | 720 | 0.610 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 2017 | 284 | 0.610 |
Why?
|
| Male | 136 | 2021 | 351093 | 0.610 |
Why?
|
| Adenoma, Oxyphilic | 2 | 2020 | 146 | 0.600 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2017 | 84 | 0.590 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2017 | 20 | 0.580 |
Why?
|
| Neoplasm Invasiveness | 15 | 2021 | 3584 | 0.580 |
Why?
|
| Physical Therapy Modalities | 5 | 2019 | 530 | 0.580 |
Why?
|
| Hydrogen | 1 | 2017 | 173 | 0.560 |
Why?
|
| Immunohistochemistry | 15 | 2019 | 11036 | 0.550 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2019 | 3742 | 0.540 |
Why?
|
| Biopsy | 11 | 2019 | 6732 | 0.510 |
Why?
|
| Keratinocytes | 4 | 2019 | 786 | 0.510 |
Why?
|
| Disulfides | 1 | 2017 | 454 | 0.510 |
Why?
|
| Neoplasm Recurrence, Local | 11 | 2018 | 9170 | 0.510 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2015 | 100 | 0.500 |
Why?
|
| Apoptosis | 12 | 2020 | 9421 | 0.500 |
Why?
|
| Scleroderma, Systemic | 1 | 2019 | 340 | 0.500 |
Why?
|
| Hematuria | 2 | 2013 | 233 | 0.490 |
Why?
|
| Humans | 169 | 2023 | 746044 | 0.480 |
Why?
|
| Adrenal Cortex Neoplasms | 2 | 2006 | 157 | 0.470 |
Why?
|
| Lymphatic Metastasis | 3 | 2020 | 2918 | 0.470 |
Why?
|
| Muscle, Smooth | 3 | 2016 | 921 | 0.460 |
Why?
|
| Aged | 66 | 2022 | 164236 | 0.450 |
Why?
|
| Middle Aged | 73 | 2021 | 214412 | 0.450 |
Why?
|
| Cell Proliferation | 18 | 2020 | 10300 | 0.440 |
Why?
|
| Cadmium | 2 | 2013 | 211 | 0.440 |
Why?
|
| Ultrasonography, Interventional | 1 | 2021 | 1478 | 0.440 |
Why?
|
| Carcinoma, Ductal | 1 | 2013 | 98 | 0.430 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 1135 | 0.430 |
Why?
|
| Metabolomics | 6 | 2019 | 1570 | 0.430 |
Why?
|
| Upper Extremity | 5 | 2019 | 646 | 0.420 |
Why?
|
| Taiwan | 9 | 2020 | 503 | 0.410 |
Why?
|
| Penile Neoplasms | 1 | 2014 | 162 | 0.410 |
Why?
|
| RNA Interference | 5 | 2017 | 2842 | 0.410 |
Why?
|
| Urothelium | 3 | 2020 | 275 | 0.400 |
Why?
|
| Cell Line, Tumor | 21 | 2020 | 16657 | 0.400 |
Why?
|
| Carcinoma, Small Cell | 2 | 2015 | 413 | 0.400 |
Why?
|
| Survival Rate | 13 | 2020 | 12632 | 0.390 |
Why?
|
| Disease-Free Survival | 11 | 2019 | 6781 | 0.390 |
Why?
|
| Angiomyolipoma | 4 | 2020 | 183 | 0.390 |
Why?
|
| Diagnosis, Differential | 12 | 2020 | 12839 | 0.380 |
Why?
|
| Kaplan-Meier Estimate | 12 | 2018 | 6453 | 0.380 |
Why?
|
| Racemases and Epimerases | 4 | 2004 | 113 | 0.380 |
Why?
|
| Urethra | 2 | 2016 | 404 | 0.380 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 3460 | 0.380 |
Why?
|
| Stroke | 11 | 2019 | 9693 | 0.380 |
Why?
|
| Reactive Oxygen Species | 8 | 2020 | 2070 | 0.360 |
Why?
|
| Receptors, Androgen | 8 | 2018 | 1065 | 0.360 |
Why?
|
| Lymphangioleiomyomatosis | 3 | 2019 | 203 | 0.360 |
Why?
|
| Membrane Proteins | 6 | 2020 | 7785 | 0.360 |
Why?
|
| Oxidative Stress | 4 | 2018 | 3025 | 0.350 |
Why?
|
| Movement | 1 | 2017 | 1464 | 0.350 |
Why?
|
| Dermatitis, Atopic | 1 | 2017 | 684 | 0.340 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 710 | 0.340 |
Why?
|
| DNA Methylation | 9 | 2020 | 4258 | 0.340 |
Why?
|
| Osteoporosis | 2 | 2017 | 1580 | 0.340 |
Why?
|
| Tuberous Sclerosis | 2 | 2014 | 1023 | 0.340 | |